CLNE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

CLNE

53.7
AI Score
VS
CLNE Wins

CLOV

41.0
AI Score

Investment Advisor Scores

CLNE

54score
Recommendation
HOLD

CLOV

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLNE CLOV Winner
Forward P/E 5.7571 81.9672 CLNE
PEG Ratio 4.7217 0 Tie
Revenue Growth 3.7% 55.6% CLOV
Earnings Growth 512.0% 0.0% CLNE
Tradestie Score 53.7/100 41.0/100 CLNE
Profit Margin -21.3% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CLNE 1M: -6.3% · 3M: -14.7% CLOV 1M: +6.2% · 3M: -1.6%

Current Technical Phase

CLNE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 45

RSI (14): 44.7 · Price: $1.63

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.4 · Price: $4.82

Fundamentals Snapshot

Metric CLNE CLOV
Market Cap
Forward P/E -46.6 32.1
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin 0.0% 0.0%
EPS -0.42 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLNE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.